
Xoma Investor Relations Material
Latest events

Status Update
Xoma

Q2 2025
28 Aug, 2025

Q1 2025
24 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xoma
Access all reports
XOMA Corporation is a biotechnology company focused on licensing and royalty acquisitions related to commercial and late-stage pharmaceutical assets. The company does not develop or market its own products but instead acquires rights to future royalty streams and milestone payments associated with therapeutic candidates developed by other companies. XOMA’s portfolio includes interests in various drug candidates across multiple therapeutic areas. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
XOM
Country
🇸🇪 Sweden